/CEL.L
CEL.L Stock - Celadon Pharmaceuticals Plc
Healthcare|Drug Manufacturers - Specialty & GenericLSE
$13.40+16.52%
+$1.90 (+16.52%) • Jul 1
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.42
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $14.74
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CEL.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$13.27 – $13.53
TARGET (TP)$15.41
STOP LOSS$12.33
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.19
52W High$83.00
52W Low$0.06
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $75,000 | $24,000 | $2,000 | N/A | N/A |
| Gross Profit | $1,000 | $-66,000 | $-10,000 | N/A | N/A |
| Gross Margin | 1.3% | -275.0% | -500.0% | N/A | N/A |
| Operating Income | $-5,931,000 | $-5,381,000 | $2.71M | $-720,647 | $-47,452 |
| Net Income | $-7,140,000 | $-17,411,000 | $-4,628,000 | $-1,059,793 | $-151,697 |
| Net Margin | -9520.0% | -72545.8% | -231400.0% | N/A | N/A |
| EPS | $-0.12 | $-0.30 | $-0.10 | $-34.43 | $0.00 |
Company Overview
Celadon Pharmaceuticals Plc, a pharmaceutical company, engages in the research, manufacture, and supply of cannabinoids for use in approved medicines. The company focuses on growing indoor hydroponic THC cannabis for use in medicinal products used to treat chronic pain. It also intends to conduct research into cannabinoids for use in chronic pain, as well as other conditions, such as autism and multiple sclerosis. The company was founded in 2018 and is headquartered in London, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CEL.LBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.05
Q4 2023
EPS Surprise History
Q4 20
No data
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q3 23
No data
Q4 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 29, 2025 | — | — | — | — |
Q2 2025 | Jun 5, 2025 | — | — | — | — |
Q3 2024 | Sep 30, 2024 | — | — | — | — |
Q2 2024 | May 14, 2024 | — | — | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.05 | — | — |
Q3 2023 | Sep 28, 2023 | — | — | — | — |
Q3 2023 | Sep 5, 2023 | — | $-0.07 | — | — |
Q2 2023 | Jun 5, 2023 | — | — | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.06 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.25 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.06 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.04 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.12 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CEL.L
What is CEL.L's current stock price?
Celadon Pharmaceuticals Plc (CEL.L) is currently trading at $13.40 per share. The stock has moved +16.52% today.
What is the analyst price target for CEL.L?
No analyst price targets are currently available for this stock.
What sector is Celadon Pharmaceuticals Plc in?
Celadon Pharmaceuticals Plc operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the LSE exchange.
What is CEL.L's market cap?
Celadon Pharmaceuticals Plc has a market capitalization of $0.01 billion, making it a small-cap company.
Does CEL.L pay dividends?
No, Celadon Pharmaceuticals Plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAVO.L
Advanced Oncotherapy plc
$1.75
Mkt Cap: $0.9B
BVX.L
BiVictriX Therapeutics Plc
$10.00
Mkt Cap: $0.8B
CNSL.L
Cambridge Nutritional Sciences plc
$2.04
Mkt Cap: $0.5B
HELD.L
Hellenic Dynamics Plc
$0.95
Mkt Cap: $0.1B
INHC.L
Induction Healthcare Group PLC
$9.75
Mkt Cap: $0.9B
MXC.L
MGC Pharmaceuticals Limited
$21.20
Mkt Cap: $0.9B
NSCI.L
NetScientific plc
$53.12
Mkt Cap: $1.3B
RGT.L
Argent BioPharma Limited
$6.00
Mkt Cap: $0.4B
SNG.L
Synairgen plc
$0.95
Mkt Cap: $1.2B
TCF.L
Theracryf Plc
$0.20
Mkt Cap: $0.4B
Explore stocks similar to CEL.L for comparison